Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01283789
Title Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Kansas
Age Groups: adult
Covered Countries USA

No variant requirements are available.